@article{10.37349/eds.2024.00062,
abstract = {Glioblastoma (GBM) remains a formidable challenge in neuro-oncology due to its aggressive nature and propensity for therapeutic resistance. Anti-vascular endothelial growth factor (VEGF) therapies, although promising, often encounter resistance that limits their clinical efficacy. A multi-target and multi-drug approach has emerged as compelling strategies to address this resistance to enhance the treatment outcomes. This review examines the complex environment of anti-VEGF resistant GBM and analyses a multi-target therapeutic approach using natural products.},
author = {Soumya, Sasikumar Jalajakumari and Arya, Kesavan Rathi and Abhinand, Chandran Sheela and Sunitha, Padmanabhan and Athira, Ajitha Prabhakaran and Nair, Achuthsankar Sukumaran and Oommen, Oommen V. and Sudhakaran, Perumana R.},
doi = {10.37349/eds.2024.00062},
journal = {Exploration of Drug Science},
pages = {567--582},
title = {{Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma}},
url = {https://www.explorationpub.com/Journals/eds/Article/100862},
volume = {2},
year = {2024},
number = {5}
}